|
FAM102B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.095400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.252000E-01 |
| Normal-vs-Stage2 |
3.211600E-01 |
| Normal-vs-Stage3 |
2.102400E-01 |
| Normal-vs-Stage4 |
4.167200E-01 |
| Stage1-vs-Stage2 |
4.330600E-01 |
| Stage1-vs-Stage3 |
2.007000E-01 |
| Stage1-vs-Stage4 |
3.452800E-01 |
| Stage2-vs-Stage3 |
9.155000E-01 |
| Stage2-vs-Stage4 |
7.283200E-01 |
| Stage3-vs-Stage4 |
7.986600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.155600E-01 |
| Normal-vs-AfricanAmerican |
6.840200E-01 |
| Normal-vs-Asian |
8.084800E-01 |
| Caucasian-vs-AfricanAmerican |
8.863400E-01 |
| Caucasian-vs-Asian |
9.718600E-01 |
| AfricanAmerican-vs-Asian |
9.880400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.038600E-01 |
| Normal-vs-Female |
1.279550E-02 |
| Male-vs-Female |
2.199500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.548600E-01 |
| Normal-vs-Extreme_Weight |
9.309200E-01 |
| Normal-vs-Obese |
1.253820E-01 |
| Normal-vs-Extreme_Obese |
1.855730E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.949400E-01 |
| Normal_Weight-vs-Obese |
1.139620E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.583840E-02 |
| Extreme_Weight-vs-Obese |
1.342180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.155400E-03 |
| Obese-vs-Extreme_Obese |
1.957910E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.939600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.520400E-02 |
| Normal-vs-Age(61-80Yrs) |
7.269000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.653000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.381200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.441400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.737800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.439760E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.335000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.678600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.745400E-01 |
| Normal-VS-Type2 PRCC |
8.838200E-01 |
| Normal-VS-KIRP CIMP |
2.086500E-02 |
| Normal-VS-Unclassified PRCC |
1.307400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.805800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.023700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.279770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.279600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.743800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.411800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.766800E-01 |
| Normal-vs-N1 |
7.769800E-02 |
| Normal-vs-N2 |
1.252370E-01 |
| N0-vs-N1 |
2.601700E-02 |
| N0-vs-N2 |
4.914200E-02 |
| N1-vs-N2 |
8.218200E-01 |
|
|
